The American Kratom Association posted a press release this past 13th of July. The press release was written by Dave Herman, Chairman of the Board of the American Kratom Association.
His press release’s purpose is very simple: update of the status of the SITSA Act and the legislative “markup” that was held by the U.S. House Judiciary Committee on July 12. They’re working hard to:
secure approval of amendments that are desperately needed to protect the rights of consumers to make their own choices about their personal health and well-being.
He disagrees with the section of the kratom community that says that the plant won’t be targeted in the SITSA act and gives a few reasons why.
Among the reasons, he mentions that:
- The language in the SITSA ACT is too brad, grants too much authority to the Attorney General and DEA, and gives far too much discretion to regulators to “overreach” and use this new statue as the basis for potential banning kratom from consumers.
He continues explaining his points by emphasizing the title SITSA: Stop the Importation and Trafficking of Synthetic Analogues Act of 2017. This bill’s purpose says that the Acts is intended “clarify how controlled substance analogues are to be regulated”. It does not limit to synthetics.
Among his concluding remarks he mention’s the AKA’s goal in all of this:
Have legislation that clearly and unambiguously restricts any police officer, any prosecutors, or any judge from arresting and convicting anyone in America of kratom sales or consumption.
AKA’s next steps:
The AKA will now focus its efforts in the House Energy and Commerce Committee, that has joint jurisdiction on the SITSA Act with the House Judiciary Committee in the U.S. House of Representatives, and ask or champions there to amend this bill to limit the discretionary authority of the Attorney General and the DEA that poses a real threat to consumer access to kratom.
Stay tuned to our Coastline Kratom posts for more updates on kratom news!